1 art rate slowing (bradycardia), syncope, or "lightheadedness".

2 ovement in standing systolic BP, symptoms of lightheadedness, and a global symptom relief score (by t

3 t in the placebo group (headache, dizziness, lightheadedness, and chronic abdominal pain).

4 rter R-R intervals and more symptoms such as lightheadedness, despite similar levels of blood pressur

5 c intolerance is a syndrome characterized by lightheadedness, fatigue, altered mentation, and syncope

6 ects were relatively mild and included rash, lightheadedness, fatigue, and musculoskeletal pain.

7 c orthostatic intolerance report symptoms of lightheadedness, fatigue, and nausea accompanied by an e

8 ly if a therapy is delivered or a feeling of lightheadedness is experienced.

9 r cognitive impairment, but without postural lightheadedness or near syncope.

10    Fifty-one cases (48%) included dizziness, lightheadedness, or a feeling of disequilibrium as the i

11 ated with reproducible symptoms of weakness, lightheadedness, or syncope.

12 nd transient, consisting mainly of sedation, lightheadedness, tachycardia, and hypotension; however,

13 dose-limiting toxicity of reversible grade 3 lightheadedness was observed.